Improving the health of people with COPD Request More Information Trial Objective Researchers want to know if an investigational medication can reduce the number of exacerbations in people with chronic obstructive pulmonary disease (COPD). They want to compare the effects, good or bad, of the investigational medication to a placebo (an inactive substance that looks the same and is administered the same as the investigational medication) on you and your COPD. In this study, participants will be given either Investigational medication or placebo (a substance that looks like the investigational medication, but has no active ingredients). They will take the assigned medication with their regular COPD medications. During clinic visits, participants will receive two injections, a blood draw, a physical exam, and a few other procedures depending on the visit. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Adults diagnosed with COPD by a physician, 12 months prior to screening and have a history of two or more moderate or severe exacerbations within a 12-month period. Age: 40-90 Gender: Any Gender Estimated Time Commitment Clinic visits every two weeks up to 62 weeks. If eligible, participants may enter an extended treatment period for up to an additional 36 weeks. × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Maria Saucedo 303.398.1220 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors Genentech, Inc. Principal Investigators Russell Bowler, MD, PhD + × Russell Bowler, MD, PhD Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine View Full Profile Patient Rating 4.3 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective Researchers want to know if an investigational medication can reduce the number of exacerbations in people with chronic obstructive pulmonary disease (COPD). They want to compare the effects, good or bad, of the investigational medication to a placebo (an inactive substance that looks the same and is administered the same as the investigational medication) on you and your COPD. In this study, participants will be given either Investigational medication or placebo (a substance that looks like the investigational medication, but has no active ingredients). They will take the assigned medication with their regular COPD medications. During clinic visits, participants will receive two injections, a blood draw, a physical exam, and a few other procedures depending on the visit.